GGrantIndex
Sort

46,585 grants matching heart failure

Advancing Geriatrics Infrastructure and Network Growth (AGING) Initiative

$957,316
Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R33 · FY2023 · AG

TRANSFORM-HF CCC

$957,255
Eric J Velazquez · Yale University · U01 · FY2021 · HL

Refanalin for lung preservation and transplantation

$957,162
Weizhong Cai · Angion Biomedica Corporation · R44 · FY2008 · HL

KLF control of aging and age-associated cardiovascular disease

$957,000
Mukesh Kumar Jain · Brown University · R35 · FY2023 · HL

Therapeutic targets in African-American youth with type 2 diabetes

$956,924
Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Circulatory system and integrated muscle tissue for drug and tissue toxicity

$956,830
George A Truskey · Duke University · UH2 · FY2013 · TR

Twice-Weekly Subcutaneous Liposome Chelator to Treat Transfusional Iron Overload

$956,715
Mark Eamon Hayes · Zoneone Pharma, Inc. · R44 · FY2016 · HD

Chronic Kidney Disease in Children (CKiD III)

$955,945
Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2013 · DK

Investigating Individual Susceptibility and Host Response in Acute Respiratory Distress Syndrome

$955,499
Nuala Jennings Meyer · University Of Pennsylvania · R35 · FY2024 · HL

Leveraging Family Data to Identify Genetic Variants for Sleep Apnea

$955,370
Susan S Redline · Brigham And Women'S Hospital · R01 · FY2015 · HL

GENHAT

$954,906
University Of Minnesota Twin Cities · R01 · FY2000 · HL

Myocardial Delivery of MMP Inhibiting Hydrogels

$954,900
Brendan Purcell · Prohibix, Llc · R44 · FY2020 · HL

Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary Fibrosis

$954,681
Joseph Patti · Fibronox, L.L.C. · R44 · FY2024 · HL

THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A

$954,552
Lynne Wagenknecht · Wake Forest University Health Sciences · N01 · FY2025 · HL

Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program

$954,150
Dike Bevis Ojji · University Of Abuja · UH3 · FY2023 · HL

Unraveling respiratory rhythm generation in medullary and supramedullary networks

$953,628
Jan M. Ramirez · Seattle Children'S Hospital · R01 · FY2024 · HL

Unraveling respiratory rhythm generation in medullary and supramedullary networks

$953,628
Jan M. Ramirez · Seattle Children'S Hospital · R01 · FY2025 · HL

Inpatient Technology-Supported Assisted Referral

$953,489
Jeffrey L Fellows · Kaiser Foundation Research Institute · U01 · FY2010 · HL

EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE

$953,224
Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2016 · HG

2/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

$952,993
Kevin J Anstrom · Univ Of North Carolina Chapel Hill · U24 · FY2025 · HL

Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort

$952,184
David Schlessinger · National Institute On Aging · ZIA · FY2017 · AG

Reading workstation for clinical contrast echocardiography

$952,016
Jiri Sklenar · Narnar, Llc · R44 · FY2023 · HL

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial

$951,993
Joerg Herrmann · Mayo Clinic Rochester · R01 · FY2019 · CA

Clinical Center for Look AHEAD: Action for Health in Diabetes

$951,773
Anne L Peters · University Of Southern California · U01 · FY2010 · DK

Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure

$951,669
Saumya Das · Massachusetts General Hospital · R35 · FY2024 · HL